VEA
MCRB icon

Virtus ETF Advisers’s Seres Therapeutics MCRB Stock Holding History

Virtus ETF Advisers’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-808
Closed -$38.5K – 451
2023
Q3 		$38.5K Sell
808
-80
-9% -$6.11K 0.02% 422
2023
Q2 		$85.1K Buy
888
+71
+9% +$7.73K 0.05% 423
2023
Q1 		$92.7K Sell
817
-314
-28% -$34K 0.05% 354
2022
Q4 		$127K Sell
1,131
-804
-42% -$108K 0.07% 399
2022
Q3 		$248K Buy
1,935
+15
+0.8% +$1.54K 0.1% 290
2022
Q2 		$132K Buy
1,920
+958
+100% +$82.5K 0.05% 345
2022
Q1 		$137K Sell
962
-57
-6% -$8.77K 0.06% 242
2021
Q4 		$170K Buy
1,019
+504
+98% +$80.1K 0.06% 284
2021
Q3 		$72K Sell
515
-26
-5% -$5.09K 0.03% 391
2021
Q2 		$258K Sell
541
-64
-11% -$27K 0.11% 207
2021
Q1 		$249K Buy
605
+10
+2% +$4.61K 0.11% 289
2020
Q4 		$291K Buy
+595
New +$348K 0.12% 226
2018
Q2 		– Sell
-3,836
Closed -$563K – 270
2018
Q1 		$563K Buy
3,836
+2,071
+117% +$397K 0.49% 107
2017
Q4 		$358K Buy
1,765
+151
+9% +$31K 0.45% 79
2017
Q3 		$518K Buy
1,614
+148
+10% +$40.5K 0.07% 87
2017
Q2 		$331K Sell
1,466
-91
-6% -$18.7K 0.05% 98
2017
Q1 		$351K Buy
1,557
+150
+11% +$30.4K 0.06% 123
2016
Q4 		$279K Buy
1,407
+1,002
+247% +$219K 0.08% 115
2016
Q3 		$100K Hold
405
– – 0.05% 151
2016
Q2 		$235K Buy
405
+76
+23% +$44.6K 0.17% 109
2016
Q1 		$175K Buy
+329
New +$172K 0.24% 106

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtus ETF Advisers's MCRB Position: Q4 2023 in Review

Virtus ETF Advisers sold out of Seres Therapeutics (MCRB) in Q4 2023, closing a stake of 808 shares — an estimated $38.5K sold.

Virtus ETF Advisers first reported a position in MCRB in Q1 2016 and held it in 21 quarters. The position peaked at $563K in Q1 2018. 102 funds tracked by Wall St. Rank hold MCRB as of Q4 2023.

  • Virtus ETF Advisers reported no remaining Seres Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Virtus ETF Advisers sold 808 Seres Therapeutics shares in Q4 2023, an estimated $38.5K.
  • Virtus ETF Advisers first reported a position in Seres Therapeutics in Q1 2016 and held it in 21 quarters.
  • Virtus ETF Advisers's Seres Therapeutics position peaked at $563K in Q1 2018.
  • 102 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2023.

Based on Virtus ETF Advisers's 13F filing for Q4 2023, filed 15 Feb 2024.